Innovative Drugs for Rare Transthyretin Diseases
BSIM Therapeutics is a biotechnology company focused on the design of high-quality, organ-specific experimental drugs for the treatment of transthyretin-associated amyloid diseases. We work closely with patients and physicians to understand and address the various clinical manifestations of disease that represent unmet medical needs.
